|Bid||47.00 x 200|
|Ask||199,999.98 x 100|
|Day's range||52.51 - 53.87|
|52-week range||38.43 - 53.87|
|PE ratio (TTM)||19.87|
|Earnings date||22 Jan 2018|
|Forward dividend & yield||0.64 (1.20%)|
|1y target est||55.83|
The Zacks Analyst Blog Highlights: Associated Banc-Corp, Hancock Holding, Heartland Financial, Synovus Financial and Zions
Zions Bancorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 83.
Zions (ZION) aims to eliminate its holding company to simplify structure with the primary objective of getting rid of the systemically important regulatory label.
Stocks that moved substantially or traded heavily Monday: Cavium Inc., up $8.19 to $84.02 The chipmaker agreed to be bought by competitor Marvell Technology for $6 billion in cash and stock. Merck & Co., ...
NEW YORK, Nov. 17, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zions ...
Smaller and mid-sized regional banks are expected to benefit from the bipartisan agreement that will lessen regulatory burden.